The store will not work correctly when cookies are disabled.
The page will load shortly, Thanks for your patience!
| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source |
| 1. | ALA5052859 | Toxicity | Cytotoxicity against mouse MC3T3-E1 cells at 1 uM measured after 24 hrs by trypan blue assay | Mus musculus | 1 | ALA5052819 | cell-based format | Patent Bioactivity Data |
| 2. | ALA5052860 | Binding | Binding affinity towards GIP receptor in human HEK293 cells measured by fluorescence assay | Homo sapiens | 10 | ALA5052819 | cell-based format | Patent Bioactivity Data |
| 3. | ALA5052861 | Binding | Binding affinity towards GLP-2 receptor in human HEK293 cells measured by fluorescence assay | Homo sapiens | 9 | ALA5052819 | cell-based format | Patent Bioactivity Data |
| 4. | ALA5052862 | Functional | Inhibition of RANKL-induced osteoclastogenesis in mouse RAW264.7 cells measured after 110 hrs by TRAcP staining based assay | Mus musculus | 10 | ALA5052819 | cell-based format | Patent Bioactivity Data |
| 5. | ALA5052863 | Toxicity | Toxicity in ovariectomized BALB/c mouse assessed as effect on body mass at 25 nmol/kg/day, sc | Mus musculus | 1 | ALA5052819 | assay format | Patent Bioactivity Data |
| 6. | ALA5052866 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg/day, sc assessed as increase in ultimate displacement of cortical bone | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 7. | ALA5052867 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg/day, sc assessed as increase in post-yield displacement of cortical bone | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 8. | ALA5052868 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg/day, sc assessed as increase in work-to-fracture of cortical bone | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 9. | ALA5052872 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg/day, sc assessed as effect on cortical bone microarchitecture | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 10. | ALA5052875 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg/day, sc assessed as reduction in trabecular bone stiffness | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 11. | ALA5052881 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as increase in collagen maturity | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 12. | ALA5052882 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as increase in collagen maturity heterogeneity | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 13. | ALA5052883 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as increase in acid phosphate content heterogeneity | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 14. | ALA5052884 | Functional | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as decrease in mean phosphate/amide ratio | Mus musculus | 1 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 15. | ALA5052888 | Toxicity | Toxicity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as effect on morphological changes in liver | Mus musculus | 2 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 16. | ALA5052889 | Toxicity | Toxicity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as effect on morphological changes in pancreas | Mus musculus | 2 | ALA5052819 | organism-based format | Patent Bioactivity Data |
| 17. | ALA5052890 | Functional | Activation of GIP receptor transfected in human HEK293 cells assessed as increase in intracellular cAMP level at 1 nM | Homo sapiens | 2 | ALA5052819 | cell-based format | Patent Bioactivity Data |
| 18. | ALA5052891 | Functional | Activation of GLP2 receptor transfected in human HEK293 cells assessed as increase in intracellular cAMP level at 1 nM | Homo sapiens | 2 | ALA5052819 | cell-based format | Patent Bioactivity Data |
| 19. | ALA5052892 | Binding | Activation of GIP/GLP2 receptor transfected in human HEK293 cells assessed as increase in intracellular cAMP level at 1 nM | Homo sapiens | 2 | ALA5052819 | cell-based format | Patent Bioactivity Data |